Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Titel:
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Auteur:
Galsky, Matthew D Arija, José Ángel Arranz Bamias, Aristotelis Davis, Ian D De Santis, Maria Kikuchi, Eiji Garcia-del-Muro, Xavier De Giorgi, Ugo Mencinger, Marina Izumi, Kouji Panni, Stefano Gumus, Mahmut Özgüroğlu, Mustafa Kalebasty, Arash Rezazadeh Park, Se Hoon Alekseev, Boris Schutz, Fabio A Li, Jian-Ri Ye, Dingwei Vogelzang, Nicholas J Bernhard, Sandrine Tayama, Darren Mariathasan, Sanjeev Mecke, Almut Thåström, AnnChristine Grande, Enrique